Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study-Reference-Cited by-同舟云学术

Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study

Published:2022-06-17 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Brás Pedro Garcia^ORCID,Mano Tânia Branco,Rito Tiago,Castelo Alexandra,Ferreira Vera,Agapito Ana,Ferreira Rui Cruz,Pinto Fatima,de Sousa Lídia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-022-07357-5.pdf

Reference16 articles.

1. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–62.

2. Freisinger E, Gerß J, Makowski L, et al. Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients. Eur Heart J. 2020;41(43):4168–77.

3. Jensen A, Idorn L, Nørager B, et al. Anticoagulation in adults with congenital heart disease: the who, the when and the how. Heart. 2015;101(6):424–9.

4. Mekaj Y, Mekaj A, Duci S, Miftari E. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967–77.

5. Yang H, Veldtman G, Bouma B, et al. Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe. Heart. 2019;6(1):e000985.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulants or vitamin K antagonists in adult patients with congenital heart disease?;European Journal of Internal Medicine;2024-06